Ghassan K. Abou-Alfa
MD, MBA
Attending Physician, Gastrointestinal Oncology Service
👥Biography 个人简介
Dr. Ghassan Abou-Alfa is a hepatobiliary medical oncologist at Memorial Sloan Kettering who led ClarIDHy establishing ivosidenib in IDH1 mutated cholangiocarcinoma. He has contributed to numerous practice changing hepatobiliary trials. His work spans first line systemic therapy to targeted agents in advanced disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ghassan K. Abou-Alfa 的研究动态
Follow Ghassan K. Abou-Alfa's research updates
留下邮箱，当我们发布与 Ghassan K. Abou-Alfa（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment